Latest Breaking News On - Mirabella financial services - Page 13 : comparemela.com

Brokers Set Expectations for Hookipa Pharma Inc s FY2028 Earnings (NASDAQ:HOOK)

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) – Equities researchers at HC Wainwright issued their FY2028 earnings per share estimates for shares of Hookipa Pharma in a report released on Monday, March 25th. HC Wainwright analyst A. He forecasts that the company will post earnings of $0.31 per share for the year. HC Wainwright currently […]

United statesHookipa pharmaAmerica corpMirabella financial servicesRoyal bankPharma incHookipa pharma incVirtu financialFree reportStreet corpGet free reportHookipa pharma daily

Adverum Biotechnologies (NASDAQ:ADVM) Upgraded by StockNews com to Hold

Adverum Biotechnologies (NASDAQ:ADVM) Upgraded by StockNews com to Hold
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

James paul scopaRenaissance technologiesAdverum biotechnologies incInvesco ltdMirabella financial servicesMillennium managementAdverum biotechnologiesFree reportDirector james paul scopaFinancial servicesGet free reportAdverum biotechnologies daily

Adverum Biotechnologies (NASDAQ:ADVM) Raised to Hold at StockNews com

Adverum Biotechnologies (NASDAQ:ADVM) Raised to Hold at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

James paul scopaSecurities exchange commissionNewtyn managementCitigroup incAdverum biotechnologies incVr adviserMirabella financial servicesAdverum biotechnologiesFree reportDirector james paul scopaExchange commissionGet free reportAdverum biotechnologies daily

Hookipa Pharma s (HOOK) Outperform Rating Reaffirmed at Royal Bank of Canada

Hookipa Pharma (NASDAQ:HOOK – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a research report issued on Monday, Benzinga reports. They currently have a $5.00 price target on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $6.50 price objective on shares […]

Hookipa pharmaRoyal bankAlyeska investment groupPharma incVirtu financialMirabella financial servicesGet free reportStreet groupSigma investmentsFinancial servicesHookipa pharma daily

Humacyte (NASDAQ:HUMA) Posts Quarterly Earnings Results, Beats Estimates By $0 01 EPS

Humacyte (NASDAQ:HUMA – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same quarter last year, the company posted ($0.21) earnings per share. Humacyte Stock Down 8.1 % Shares of NASDAQ […]

United statesEudaimonia partnersAmerican international group incMirabella financial servicesEnsign peak advisors incHumacyte incGet free reportYahoo financeStock downPeak advisors incInternational groupFinancial servicesHumacyte dailyNasdaq huma